Ignite Creation Date:
2024-05-05 @ 8:02 PM
Last Modification Date:
2024-10-26 @ 9:57 AM
Study NCT ID:
NCT00784147
Status:
COMPLETED
Last Update Posted:
2014-05-05
First Post:
2008-10-30
Brief Title:
Dose-Response Study of Ibalizumab Monoclonal Antibody Plus Optimized Background Regimen in Patients With HIV-1
Sponsor:
TaiMed Biologics Inc
Organization:
TaiMed Biologics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-08
Start Date Type:
None
Primary Completion Date:
2011-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-04
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-30
First Submit QC Date:
October 30 2008
Study First Post Date:
2008-11-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2014-04-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-04-17
Last Update Post Date:
2014-05-05
Last Update Post Date Type:
ESTIMATED